Prelude Capital Management’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q4 | – | Sell |
-36,210
| Closed | -$1.57M | – | 1807 |
|
|
2015
Q3 | $1.57M | Sell |
36,210
-13,880
| -28% | -$600K | 0.23% | 96 |
|
|
2015
Q2 | $2.12M | Buy |
50,090
+35,000
| +232% | +$1.48M | 0.3% | 73 |
|
|
2015
Q1 | $585K | Sell |
15,090
-100
| -0.7% | -$3.88K | 0.08% | 284 |
|
|
2014
Q4 | $511K | Buy |
15,190
+3,100
| +26% | +$104K | 0.07% | 277 |
|
|
2014
Q3 | $423K | Hold |
12,090
| – | – | 0.06% | 391 |
|
|
2014
Q2 | $397K | Sell |
12,090
-4,100
| -25% | -$135K | 0.05% | 411 |
|
|
2014
Q1 | $597K | Sell |
16,190
-12,930
| -44% | -$477K | 0.08% | 288 |
|
|
2013
Q4 | $1.12M | Buy |
29,120
+8,500
| +41% | +$326K | 0.18% | 105 |
|
|
2013
Q3 | $565K | Sell |
20,620
-7,100
| -26% | -$195K | 0.09% | 229 |
|
|
2013
Q2 | $582K | Buy |
+27,720
| New | +$582K | 0.12% | 186 |
|